↓ Skip to main content

Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial

Overview of attention for article published in Annals of Surgical Oncology, June 2016
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 X users

Citations

dimensions_citation
238 Dimensions

Readers on

mendeley
197 Mendeley
Title
Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial
Published in
Annals of Surgical Oncology, June 2016
DOI 10.1245/s10434-016-5286-0
Pubmed ID
Authors

Robert H. I. Andtbacka, Merrick Ross, Igor Puzanov, Mohammed Milhem, Frances Collichio, Keith A. Delman, Thomas Amatruda, Jonathan S. Zager, Lee Cranmer, Eddy Hsueh, Lisa Chen, Mark Shilkrut, Howard L. Kaufman

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 197 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Unknown 196 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 37 19%
Researcher 23 12%
Student > Ph. D. Student 22 11%
Student > Master 20 10%
Other 14 7%
Other 27 14%
Unknown 54 27%
Readers by discipline Count As %
Medicine and Dentistry 54 27%
Biochemistry, Genetics and Molecular Biology 28 14%
Agricultural and Biological Sciences 14 7%
Immunology and Microbiology 14 7%
Pharmacology, Toxicology and Pharmaceutical Science 12 6%
Other 16 8%
Unknown 59 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 April 2021.
All research outputs
#15,232,080
of 26,017,215 outputs
Outputs from Annals of Surgical Oncology
#4,339
of 7,543 outputs
Outputs of similar age
#199,533
of 373,194 outputs
Outputs of similar age from Annals of Surgical Oncology
#89
of 177 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,543 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.6. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 373,194 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 177 others from the same source and published within six weeks on either side of this one. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.